Amlodipine And Atorvastatin Tablet, Film Coated
Product Images NDC 46708-764

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Amlodipine And Atorvastatin (NDC 46708-764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets (Amloatorva 10 10 mg)

Label for Amlodipine and Atorvastatin Tablets, USP, 10 mg/10 mg strength, film-coated oral tablets. The label indicates the product is Rx only and contains 30 tablets. It is manufactured by Alembic Pharmaceuticals Limited with detailed dosage and composition information. Storage instructions and NDC number 46708-762-30 are also shown.*

FDA Label Image

30 Tablets (Amloatorva 10 20 mg)

Label for Amlodipine and Atorvastatin Tablets, USP, film-coated, 10 mg/20 mg strength. The package contains 30 tablets and is labeled Rx only. Manufactured by Alembic Pharmaceuticals Limited, the label includes storage instructions and a barcode along with the NDC number 46708-763-30.*

FDA Label Image

30 Tablets (Amloatorva 10 40 mg)

A packaging label for Amlodipine and Atorvastatin Tablets USP, 10 mg/40 mg strength. The label states the product contains 30 film-coated tablets, is Rx only, and is manufactured by Alembic Pharmaceuticals Limited in India. The label includes dosage and use information, storage instructions, barcode, lot, and expiration date fields.*

FDA Label Image

30 Tablets (Amloatorva 10 80 mg)

Label for Amlodipine and Atorvastatin Tablets, USP, containing 10 mg of amlodipine and 80 mg of atorvastatin per tablet. The film-coated tablets are manufactured by Alembic Pharmaceuticals Limited and come in a package of 30 tablets. The label includes dosage strength, lot, and expiration space, storage instructions, and a barcode.*

FDA Label Image

30 Tablets (Amloatorva 25 10 mg)

Label for Amlodipine and Atorvastatin Tablets, USP 2.5 mg/10 mg, oral film-coated tablets. The label shows a 30 count package by Alembic Pharmaceuticals Limited, including dosage details and storage instructions. The lot and expiration fields are blank.*

FDA Label Image

30 Tablets (Amloatorva 25 20 mg)

A rectangular pink and white blister pack label for Amlodipine and Atorvastatin Tablets, USP, containing 2.5 mg of Amlodipine and 20 mg of Atorvastatin per tablet. The label displays the NDC number 46708-756-30, states the package contains 30 tablets, and references Alembic Pharmaceuticals Limited as the manufacturer. It notes child-resistant packaging and includes storage instructions and a barcode area.*

FDA Label Image

30 Tablets (Amloatorva 25 40 mg)

Label for Amlodipine and Atorvastatin Tablets USP, film-coated, oral dosage form, strength 2.5 mg/40 mg. The label states it contains 30 tablets, is Rx only, and is manufactured by Alembic Pharmaceuticals Limited. Storage instructions and barcode are also visible.*

FDA Label Image

30 Tablets (Amloatorva 5 10 mg)

Label for Amlodipine and Atorvastatin Tablets, USP, with strength 5 mg/10 mg. It is a package containing 30 tablets, labeled Rx only. The label includes manufacturer information for Alembic Pharmaceuticals Limited, dosage instructions to see accompanying prescribing information, and a child-resistant packaging notice.*

FDA Label Image

30 Tablets (Amloatorva 5 20 mg)

Amlodipine and Atorvastatin Tablets, USP label for 5 mg/20 mg film-coated tablets in a 30-tablet package. The label shows the NDC 46708-759-30 and includes manufacturer information for Alembic Pharmaceuticals Limited. It also lists storage instructions and notes the product is prescription only.*

FDA Label Image

30 Tablets (Amloatorva 5 40 mg)

Amlodipine and Atorvastatin Tablets, USP label for 5 mg/40 mg strength, film-coated oral tablets. The label shows dosage strength, quantity of 30 tablets, and manufacturer Alembic Pharmaceuticals Limited. Includes NDC 46708-760-30, bar code, storage instructions, and child-resistant packaging notice.*

FDA Label Image

30 Tablets (Amloatorva 5 80 mg)

Amlodipine and Atorvastatin Tablets, USP 5 mg/80 mg film-coated tablets in a 30-tablet package. The label includes manufacturer information for Alembic Pharmaceuticals Limited, dosage details, and storage instructions. The label also displays the NDC number 46708-761-30 and a barcode.*

FDA Label Image

Amloatorva-amlodipine.jpg (Amloatorva Amlodipine)

Chemical structure diagram showing the molecular formula of Amlodipine and Atorvastatin, visually representing atoms and bonds that make up the compound. The structure includes characteristic ring systems and functional groups associated with these active ingredients.*

FDA Label Image

Amloatorva-atorvastatin.jpg (Amloatorva Atorvastatin)

Chemical structure of the active ingredient Atorvastatin calcium trihydrate, showing its molecular formula with aromatic rings, hydroxyl groups, and calcium with water molecules.*

FDA Label Image

Figure 1 (Amloatorva Fig 1)

A line graph showing event rate over time (months) comparing Amlodipine and Placebo groups. The x-axis represents time in months up to 24, and the y-axis shows event rate ranging approximately from 0 to 0.25. Numbers at risk are displayed below the time points. Two curves depict cumulative event rates, with the Placebo group consistently higher than the Amlodipine group.*

FDA Label Image

Amloatorva-fig3.jpg (Amloatorva Fig3)

A line chart depicting cumulative incidence (%) over 3.5 years comparing Atorvastatin (solid line) and Placebo (dashed line). The chart shows that Atorvastatin has a lower cumulative incidence than Placebo. The hazard ratio (HR) is 0.64 with a confidence interval from 0.5 to 0.83 and a p-value of 0.0005.*

FDA Label Image

Amloatorva-fig4.jpg (Amloatorva Fig4)

A line graph showing cumulative hazard percentage over time (years) to the first primary endpoint through four years of follow-up, comparing placebo (dashed line) and atorvastatin (solid line). The graph includes a hazard ratio (HR 0.63) with confidence interval (0.48 to 0.83) and a p-value (0.001).*

FDA Label Image

Amloatorva-fig5.jpg (Amloatorva Fig5)

A line graph comparing the cumulative percentage of subjects experiencing a major cardiovascular event over a 5-year period for two Atorvastatin dosage groups: 10 mg and 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The 10 mg group shows a higher event rate compared to the 80 mg group, with a hazard ratio of 0.78 (95% CI 0.69 to 0.89) and a p-value of 0.0002.*

FDA Label Image

Amloatorva-figure-2.jpg (Amloatorva Figure 2)

A forest plot showing hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo among various patient subgroups, including overall patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The horizontal axis ranges from 0 to 2, with a vertical reference line at 1 indicating no effect.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.